FOSFOFAST INJ 4G

About FOSFOFAST INJ 4G

Brand: FOSFOFAST 4
Content / Active Ingredient: Fosfomycin Sodium Injection
Strength: 4 g per vial
Company / Manufacturer: BDR Pharmaceutical
Pack Size: 4 g Vial (Dry Powder for Injection)

FOSFOFAST 4 Injection is a sterile injectable antibiotic formulation containing Fosfomycin Sodium 4 g, a broad-spectrum bactericidal agent used in the treatment of serious bacterial infections. It is supplied as a dry powder for reconstitution and is intended for intravenous administration under the supervision of a qualified healthcare professional.

Fosfomycin Sodium works by inhibiting bacterial cell wall synthesis at an early stage, making it effective against a wide range of Gram-positive and Gram-negative organisms, including certain multidrug-resistant strains. It is commonly used in hospital settings for moderate to severe infections.

         Composition: Fosfomycin Sodium 4 g per vial

         Therapeutic Category: Antibiotic Phosphonic acid derivative

         Dosage Form: Sterile dry powder for IV injection/infusion

         Route of Administration: Intravenous (IV) use only

         Prescription Status: Schedule H Prescription medicine

         Packaging: 4 g single vial pack

         Storage: Store in a cool, dry place below recommended temperature

FOSFOFAST 4 Injection is indicated for the treatment of:

         Severe urinary tract infections

         Respiratory tract infections

         Intra-abdominal infections

         Septicemia (bloodstream infections)

         Bone and joint infections

         Infections caused by multidrug-resistant organisms

Dosage and duration should be determined by a qualified healthcare professional based on infection severity and patient condition.

Fosfomycin inhibits the initial step of bacterial cell wall synthesis by blocking the formation of peptidoglycan, leading to bacterial cell death.

         To be administered only by trained healthcare professionals.

         Monitor renal function and electrolyte levels during prolonged therapy.

         Possible side effects include nausea, diarrhea, headache, rash, and injection-site reactions.